Cargando…
COVID-19: Gastrointestinal manifestations, liver injury and recommendations
Coronavirus disease 2019 (COVID-19) has caused a pandemic that affected all countries with nearly 270 million patients and 5 million deaths, as of as of December, 2021. The severe acute respiratory syndrome coronavirus 2 virus targets the receptor, angiotensin-converting enzyme 2, which is frequentl...
Autores principales: | Ozkurt, Zulal, Çınar Tanrıverdi, Esra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855202/ https://www.ncbi.nlm.nih.gov/pubmed/35211548 http://dx.doi.org/10.12998/wjcc.v10.i4.1140 |
Ejemplares similares
-
Gastrointestinal and Liver Manifestations of COVID-19
por: Agarwal, Amol, et al.
Publicado: (2020) -
Gastrointestinal and liver manifestations of COVID-19
por: Cheong, Janice, et al.
Publicado: (2020) -
Gastrointestinal and liver manifestations in patients with COVID-19
por: Lee, I-Cheng, et al.
Publicado: (2020) -
Gastrointestinal and Liver Manifestations in COVID-19 Population
por: Saleem, Saad, et al.
Publicado: (2021) -
COVID-19: gastrointestinal and hepatobiliary manifestations()()
por: Shih, Angela R., et al.
Publicado: (2023)